Intracellular interleukin 6 mediates platelet-derived growth factor-induced proliferation of nontransformed cells.

Michael Roth, Markus Nauck, M. Tamm, André P. Perruchoud, Rolf Ziesche, L H BlockProceedings of the National Academy of Sciences 1995 · DOI

TL;DR

This paper reveals that interleukin-6 (IL-6), a cytokine typically thought to act extracellularly, plays a crucial intracellular role in mediating the growth-promoting effects of platelet-derived growth factor (PDGF) in normal cells. By using antisense oligonucleotides to block IL-6 production, the researchers found that PDGF-induced cell proliferation was significantly inhibited, suggesting a novel, non-canonical signaling pathway for growth factors.

What Problem Does This Paper Address?

Interleukin-6 (IL-6) is a well-known cytokine involved in immune responses and inflammation, and its role in promoting the growth of certain cancer cells has been established. However, its function in the proliferation of normal, non-transformed cells, particularly in response to growth factors like PDGF, was not well understood. While PDGF is a potent mitogen known to induce cell division, the precise intracellular mechanisms by which it achieves this in normal cells remained an open question. This paper investigates whether IL-6, which is known to be induced by PDGF, acts as an extracellular signal or if it has a more direct, intracellular role in mediating PDGF-driven proliferation.

Methods

The researchers employed a combination of molecular biology and cell culture techniques:

  • Cell Cultures: Primary human lung fibroblasts, vascular smooth muscle cells (VSMCs), and mesangial cells (MCs) were used. These cells were growth-arrested to ensure a synchronized starting point for experiments.
  • Stimulation: Cells were stimulated with different isoforms of PDGF (PDGF-AA, -AB, and -BB) at their respective effective doses.
  • Antisense Oligonucleotides: This was the key experimental tool. Phosphorothioate-modified oligonucleotides (PTOs) designed to be complementary to IL-6 mRNA (antisense) were used to specifically inhibit IL-6 gene expression. Control experiments used sense PTOs (complementary to the antisense sequence) and IL-6 receptor (IL-6-R) antisense PTOs to rule out non-specific effects.
  • Gene Expression Analysis:
    • Northern Blotting: Used to measure mRNA levels of IL-6, CDC2 (a cell cycle regulator), and PCNA (proliferating cell nuclear antigen), which are all markers of cell proliferation.
  • Immunofluorescence: Used to visualize the intracellular localization and abundance of IL-6 protein.
  • Proliferation Assays:
    • [³H]thymidine Incorporation: Measures de novo DNA synthesis, a direct indicator of cell division.
  • Cell Counting: Quantifies the overall increase in cell numbers over time.
  • Secretion Assays: Enzyme immunoassay (EIA) was used to measure the amount of IL-6 secreted into the cell culture supernatant.

Datasets

Not discussed in the paper. The experiments utilized primary human cell cultures and recombinant PDGF isoforms.

Key Insights and Ideas

  • Intracellular IL-6 as a Growth Mediator: The most significant finding is that IL-6 doesn't just act as an extracellular signal; it appears to function inside the cell to mediate PDGF-induced proliferation. This challenges the traditional view of cytokines as solely paracrine or endocrine factors.
  • PDGF Induces IL-6 Expression: Consistent with prior work, PDGF was shown to upregulate IL-6 gene expression, translation, and secretion in multiple cell types.
  • Antisense Blockade is Effective: Specifically blocking IL-6 production with antisense oligonucleotides significantly inhibited PDGF-induced cell division, DNA synthesis, and the expression of key cell cycle genes (CDC2, PCNA).
  • Extracellular IL-6 is Not the Primary Driver: Neutralizing antibodies against extracellular IL-6, and even blocking the IL-6 receptor with antisense oligonucleotides, did not inhibit PDGF-induced proliferation. This strongly supports the intracellular mechanism.
  • Common Pathway for Mitogens: The authors propose that intracellular IL-6 might be part of a final common pathway for various mitogenic signals, not just PDGF, as similar inhibition was observed with fetal calf serum (FCS).

Key Results

  • All three PDGF isoforms (AA, AB, BB) induced IL-6 gene expression and cell proliferation in fibroblasts, VSMCs, and MCs.
  • IL-6 antisense oligonucleotides, but not IL-6 sense oligonucleotides, dose-dependently inhibited PDGF-induced DNA synthesis and cell counts.
  • At a concentration of 10 µM, IL-6 antisense PTOs completely abolished PDGF-induced proliferation.
  • IL-6 antisense PTOs also significantly reduced intracellular IL-6 protein levels (visualized by immunofluorescence) and suppressed the PDGF-induced transcription of CDC2 and PCNA genes.
  • Neutralizing anti-IL-6 antibodies and IL-6-R antisense PTOs had no significant inhibitory effect on PDGF-induced proliferation.

Limitations and Future Work

  • Mechanism of Intracellular Action: While the paper demonstrates that intracellular IL-6 is essential, the precise molecular mechanism by which it acts within the cell to promote proliferation remains to be elucidated.
  • Specific Cellular Compartment: The study doesn't pinpoint the exact intracellular compartment where IL-6 exerts its effect.
  • Generalizability: While tested in three cell types, further studies are needed to confirm if this intracellular IL-6 mechanism is conserved across a broader range of nontransformed cells and in response to other growth factors.
  • Future Directions: The authors suggest further research is needed to precisely understand how IL-6 gene activation contributes to cell cycle progression and to explore the intracellular signaling pathways involved. They also propose investigating whether this intracellular mechanism is conserved in other cell types and in response to different mitogens.

Summary updated

Abstract

The functional relevance of interleukin 6 (IL-6) in platelet-derived growth factor (PDGF)-induced cell growth was evaluated in cultures of human fibroblasts, vascular smooth muscle cells, and mesangial cells. The three isoforms of the PDGF--namely, PDGF-AA, -AB, and -BB--induced the expression of the IL-6 gene and proliferation of the nontransformed cells. PDGF-induced transcription, translation, and secretion of IL-6 were diminished in the presence of IL-6 antisense oligonucleotides. While neutralizing anti-IL-6 antibodies failed to affect the growth factor-dependent cell proliferation, IL-6 antisense oligonucleotides inhibited cell division. In addition, IL-6 antisense oligonucleotides abolished PDGF-induced transcription of the genes coding for the cell division cycle 2-related protein (CDC2) and proliferating cell nuclear antigen (PCNA), both of which are regulated in a cell cycle-dependent manner. It is concluded that PDGF-dependent proliferation of nontransformed cells involves the action of intracellular IL-6.
BibTeX
@inproceedings{roth1995intracellular,
  author = {Michael Roth and Markus Nauck and M. Tamm and André P. Perruchoud and Rolf Ziesche and L H Block},
  title = {{Intracellular interleukin 6 mediates platelet-derived growth factor-induced proliferation of nontransformed cells.}},
  booktitle = {Proceedings of the National Academy of Sciences},
  year = {1995},
  doi = {10.1073/pnas.92.5.1312},
}

Loading related content...

Figure